Premium
Endoscopic management of combined malignant biliary and gastric outlet obstruction
Author(s) -
Nakai Yousuke,
Hamada Tsuyoshi,
Isayama Hiroyuki,
Itoi Takao,
Koike Kazuhiko
Publication year - 2017
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/den.12729
Subject(s) - medicine , gastric outlet obstruction , endoscopic ultrasound , endoscopic stenting , endoscopic retrograde cholangiopancreatography , biliary drainage , stent , radiology , percutaneous , pancreatic cancer , cancer , surgery , pancreatitis
Patients with periampullary cancer or gastric cancer often develop malignant biliary obstruction (MBO) and gastric outlet obstruction (GOO), and combined MBO and GOO is not rare in these patients. Combined MBO and GOO is classified by its location and sequence, and treatment strategy can be affected by this classification. Historically, palliative surgery, hepaticojejunostomy and gastrojejunostomy were carried out, but the current standard treatment is combined transpapillary stent and duodenal stent placement. Although a high technical success rate is reported, the procedure can be technically difficult and duodenobiliary reflux with subsequent cholangitis is common after double stenting. Recent development of endoscopic ultrasound (EUS)‐guided procedures enables the management of MBO as well as GOO under EUS guidance. EUS‐guided biliary drainage is now increasingly reported as an alternative to percutaneous transhepatic biliary drainage in failed endoscopic retrograde cholangiopancreatography (ERCP), and GOO is one of the major reasons for failed ERCP. In addition to EUS‐guided biliary drainage, the feasibility of EUS‐guided double‐balloon‐occluded gastrojejunostomy bypass for MBO was recently reported, and EUS‐guided double stenting can potentially become the treatment of choice in the future. However, as each procedure has its advantages and disadvantages, treatment strategy should be selected based on the type of obstruction and the prognosis and performance status of the patient.